Literature DB >> 16759092

Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements.

Alexandra L Klinger1, David F McComsey, Virginia Smith-Swintosky, Richard P Shank, Bruce E Maryanoff.   

Abstract

This paper examines the relative effectiveness of bioisosteric sulfamate and sulfamide derivatives for inhibition of human carbonic anhydrase-II (CA-II) by using a direct binding assay based on the ThermoFluor method (Matulis et al. Biochemistry 2005, 44, 5258). Compounds 1-10, which represent five cognate sulfamate/sulfamide pairs, were studied by ThermoFluor to obtain binding affinities (K(a) values). The corresponding dissociation constants, K(d), provide an independent measure of CA-II activity relative to commonly used K(i) values from enzyme kinetics studies. There was a sizable difference in potency between the sulfamates and sulfamides, with the sulfamides being much less potent, by factors ranging from 25 (7/8) to 1,200 (3/4). These results are consistent with our recent report that sulfamides tend to be much weaker inhibitors of CA-II than their corresponding sulfamates (Maryanoff et al. J. Med. Chem. 2005, 48, 1941). Additionally, for arylsulfamides 10-12 the K(d) values determined by ThermoFluor and the K(i) values determined from enzyme kinetics are consistent. It appears that the sulfamide group is less suitable than the sulfamate group for obtaining potent inhibition of CA-II.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759092     DOI: 10.1021/jm058279n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).

Authors:  David F McComsey; Virginia L Smith-Swintosky; Michael H Parker; Douglas E Brenneman; Ewa Malatynska; H Steve White; Brian D Klein; Karen S Wilcox; Michael E Milewski; Mark Herb; Michael F A Finley; Yi Liu; Mary Lou Lubin; Ning Qin; Allen B Reitz; Bruce E Maryanoff
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

2.  A quantitative model of thermal stabilization and destabilization of proteins by ligands.

Authors:  Piotras Cimmperman; Lina Baranauskiene; Simona Jachimoviciūte; Jelena Jachno; Jolanta Torresan; Vilma Michailoviene; Jurgita Matuliene; Jolanta Sereikaite; Vladas Bumelis; Daumantas Matulis
Journal:  Biophys J       Date:  2008-07-03       Impact factor: 4.033

Review 3.  Characterization of aminoacyl-tRNA synthetase stability and substrate interaction by differential scanning fluorimetry.

Authors:  Jamie A Abbott; Nathan M Livingston; Shawn B Egri; Ethan Guth; Christopher S Francklyn
Journal:  Methods       Date:  2016-10-26       Impact factor: 3.608

Review 4.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

5.  A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli.

Authors:  Ellen Z Baum; Steven M Crespo-Carbone; Alexandra Klinger; Barbara D Foleno; Ignatius Turchi; Mark Macielag; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

6.  Effect of topiramate on acid-base balance: extent, mechanism and effects.

Authors:  Nasir Mirza; Anthony G Marson; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2009-11       Impact factor: 4.335

7.  Hydrophobic substituents of the phenylmethylsulfamide moiety can be used for the development of new selective carbonic anhydrase inhibitors.

Authors:  Giuseppina De Simone; Ginta Pizika; Simona Maria Monti; Anna Di Fiore; Jekaterina Ivanova; Igor Vozny; Peteris Trapencieris; Raivis Zalubovskis; Claudiu T Supuran; Vincenzo Alterio
Journal:  Biomed Res Int       Date:  2014-09-02       Impact factor: 3.411

8.  An update on anticancer drug development and delivery targeting carbonic anhydrase IX.

Authors:  Justina Kazokaitė; Ashok Aspatwar; Seppo Parkkila; Daumantas Matulis
Journal:  PeerJ       Date:  2017-11-23       Impact factor: 2.984

Review 9.  Biophysical, Biochemical, and Cell Based Approaches Used to Decipher the Role of Carbonic Anhydrases in Cancer and to Evaluate the Potency of Targeted Inhibitors.

Authors:  Mam Y Mboge; Anusha Kota; Robert McKenna; Susan C Frost
Journal:  Int J Med Chem       Date:  2018-07-16

10.  Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII.

Authors:  Miglė Kišonaitė; Asta Zubrienė; Edita Capkauskaitė; Alexey Smirnov; Joana Smirnovienė; Visvaldas Kairys; Vilma Michailovienė; Elena Manakova; Saulius Gražulis; Daumantas Matulis
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.